The Slovenian project received an ERC value of 2.4 million euro



[ad_1]

Jernej Uletu, the European Research Council, agreed to funding for the integration of molecules in the brain. The Institute receives chemistry of € 2.4 million.

Slovenian researcher working in London, Jernej Ule, who have received the European Research Council (ERC) project for established researchers held by the Chemical Institute. In a 2.4 million euros project, it examines molecular linkages in the brain and the impact of links on the neurodegenerative disease course, such as ALS.

Over 2050 applications for ERC Advanced 2018 grants were received for established researchers, with only 11% selected for funding, which demonstrates the success of the Slovenian research.


Gregor Anderluh (pictured): "Over 2050 applications have been received for ERC Advanced 2018 grant for established researchers, while only 11% were selected for funding, which shows the success of the Slovenian researcher. "

Ule, with assistance from the ERC fund at the Chemistry Institute, will be setting up a new research body, according to the Chemical Institute's director. Gregor Anderluh the Molecular Biological Department and Nanobiotechnology have approximately six to eight researchers. The project will also be implemented London University College (UCL).

A five-year project entitled title RNP Dynamics a study of the RNA molecule ruling contributes to the development and functioning of the brain and as a result of errors in this rule to neurodegenerative diseases such as amyotrophic axial sconrosis (ALS), a Slovenian researcher and professor. molecular brains at UCL Ule through video-conferencing.

In addition, the project will also investigate how the bad jobs in proteins and RNAs hurt the neurons and cause the disease of ALS. This will form the basis for developing new strategies for disease management using RNA recommendations.

According to Anderlech, this is a fundamental research project that does not develop ALS drugs, but they will have a better understanding of the reasons for this infection. “I am sure that the project outcomes will underpin the development of medicines and strategies to heal the future of the disease,” said Anderluh.

The Uletov project is the eighth ERC project, being conducted by the Slovenian research organization and the fifth project in the scheme for established researchers. The second SloC SloC project is in Chemical Chemical, the first to be known as MaCChines, last year by Roman Jerala.

[ad_2]
Source link